Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Invitrogen Corp.

BioPhotonics
May 2007
In California, Invitrogen Corp. of Carlsbad will partner with Emiliem Inc. of Emeryville to screen the latter’s cancer-targeting multiple kinase inhibitors. Under terms of the agreement, Invitrogen will use its SelectScreen kinase profiling system to confirm the potency and specificity of compounds created using Emiliem’s K-Star technology. In the second phase of investigations, the former company will analyze with its cellular profiling system how the compounds influence biological pathways. Through cytochrome P450 screening, the company will assess the inhibitory effects of the molecules on drug-metabolizing liver enzymes as well.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!